Prenetics Global Ltd (PRE) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of Prenetics Global Ltd stock $3.04, price $17.35, upside -82.5%, quality 40 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?No
Good quality?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 25, 2026.
How to read this chart
60‑month range $2.90 – $120.81 · fair‑value band $2.02 – $3.81 · the $17.35 price screens above the $3.04 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 25, 2026.
Follow Prenetics Global in your weekly email
Every Wednesday you see whether Prenetics Global is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
Show moreShow less
It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Stock analysis
Prenetics Global Ltd (PRE) currently trades at $17.35, while our model-based Fair Value estimate is $3.04, 82.5% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: $2.02 (bear) to $3.81 (bull), the price of $17.35 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Prenetics Global Ltd reported revenue of $92.4M in FY2025 versus $12.5M in FY2021, a compound +64.8%/yr. Reported net income was −$37.7M in FY2025.
Key figures
Market cap $338M Small · P/S ratio 2.19 · EPS (TTM) $−3.46 · Net margin −30.4% · Return on equity −47.0% · Return on assets (EBIT) −24.2% · Operating margin −45.1% · Revenue (TTM) $155M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).
What moves the price
The share trades about 34% below its 52-week high and 47% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −82%, PRE screens richer than that median.
Fair Value models
Bear$2.02Fair Value $3.04Bull$3.81
Price $17.35 · Upside -82.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham)$2.37$3.58$4.4855
All 1 models by family
Asset-Based
NCAV (Graham)$2.37$3.58$4.4855
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.20/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+201.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+91.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
Start year 2020 (pandemic). Over 10 years: −33.5% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.6%
’10
’11
’12
’13
’14
’15
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.5% (2020) → −41.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
News mood ⓘNews mood, the average tone of recent news (95 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 615 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score40 · Bottom 25%
Fair Value upside−82.5% · Bottom 25%
Profitability
Return on assets−18.5% · Bottom 25%
Net margin (12 months)−30.4% · Bottom 25%
Operating margin (12 months)−45.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)210.7% · Top 25%
Balance sheet
Debt / equity4.70× · Highest 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/B1.94× · Pricier than median
P/S (12 months)2.19× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 37
FUTURE (revenue growth)100· sector 23
PAST (return on equity)0· sector 31
HEALTH (low debt)0· sector 96
DIVIDEND (yield)0· sector 58
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Prenetics Global Ltd Fair Value". https://www.fairvalue-calculator.com/stock/PRE
Frequently asked questions
Is Prenetics Global Ltd (PRE) overvalued or undervalued?
As of Oct 25, 2026, our model estimates a fair value of $3.04 versus a price of $17.35, about −82% upside (overvalued).
What is the fair value of PRE?
Our model-based fair value for Prenetics Global Ltd is $3.04 (as of Oct 25, 2026), built from audited fundamentals. The current price: $17.35.
What is the quality score of PRE?
Prenetics Global Ltd has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Prenetics Global Ltd (PRE)?
Our model-based price target is the fair value of $3.04 (as of Oct 25, 2026) from 1 valuation models. Cautious scenario $2.02, optimistic scenario $3.81. It is a calculation from audited fundamentals, not an analyst target.
What is the Prenetics Global Ltd stock forecast for 2026?
Our models put fair value at $3.04, about −82% upside versus a price of $17.35 (overvalued). Cautious scenario $2.02, optimistic scenario $3.81. The calculation is refreshed regularly with new filings.
What is the revenue of Prenetics Global Ltd (PRE)?
Prenetics Global Ltd reported trailing-twelve-month revenue of about $155M (latest available figure, as of Oct 25, 2026).
What is the intrinsic value of Prenetics Global Ltd (PRE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Prenetics Global Ltd it is $3.04 per share (as of Oct 25, 2026), against a price of $17.35. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Prenetics Global Ltd stock overvalued or undervalued in 2026?
As of Oct 25, 2026, PRE trades above its calculated fair value: price $17.35, fair value $3.04, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PRE?
No. The price is what the market pays today ($17.35); the fair value is what the company's own numbers justify ($3.04). For Prenetics Global Ltd the two are $14.31 per share apart. That gap is exactly why we show both numbers side by side.
How much is Prenetics Global Ltd worth?
The market values Prenetics Global Ltd at about $338M (market capitalisation, as of Oct 25, 2026). Per share that is $17.35; our models calculate a fair value of $3.04 per share.
What do the bullish and bearish scenarios say about PRE?
Our models span a range for Prenetics Global Ltd: cautious scenario $2.02, base $3.04, optimistic $3.81 per share (as of Oct 25, 2026, price $17.35). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Prenetics Global Ltd (PRE)?
Balance-sheet figures for Prenetics Global Ltd (as of Oct 25, 2026): return on equity −47.0%, debt of 4.70 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is PRE from its 52-week high?
Prenetics Global Ltd trades at $17.35, about 34% below its 52-week high of $26.25 and 47% above the low of $11.79 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of $3.04 is for.
Which stocks are comparable to Prenetics Global Ltd?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Prenetics Global Ltd stock attractive at the current price?
The data as of Oct 25, 2026: price $17.35, calculated fair value $3.04 (−82%), Quality Score 40/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PRE calculated?
We run Prenetics Global Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $3.04, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. Prenetics Global Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Prenetics Global Ltd (PRE)?
The closing price on Oct 23, 2026 was $17.35. Our model-based fair value is $3.04, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Prenetics Global Ltd right now?
The price sits above even our optimistic bull case ($3.81). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($2.02 to $3.81) leaves room in how you read the outcome.
Key figures of Prenetics Global Ltd
How large is the market capitalisation of Prenetics Global Ltd (PRE)?
The market capitalisation of Prenetics Global Ltd is $338M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Prenetics Global Ltd (PRE)?
The price-to-sales ratio of Prenetics Global Ltd is 2.19 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Prenetics Global Ltd (PRE)?
Earnings per share at Prenetics Global Ltd are $−3.46. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Prenetics Global Ltd (PRE)?
The net margin of Prenetics Global Ltd is −30.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Prenetics Global Ltd (PRE)?
The return on equity (ROE) of Prenetics Global Ltd is −47.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Prenetics Global Ltd (PRE)?
On an EBIT basis the return on assets of Prenetics Global Ltd is −24.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Prenetics Global Ltd (PRE)?
The operating margin of Prenetics Global Ltd is −45.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Prenetics Global Ltd (PRE)?
Revenue at Prenetics Global Ltd is growing +211% versus a year earlier (3y avg +91.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Prenetics Global Ltd (PRE) generate?
The free cash flow of Prenetics Global Ltd is −$22.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Prenetics Global Ltd (PRE) hold?
Prenetics Global Ltd holds more cash than debt, $29.9M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Prenetics Global Ltd in the live analysis
One click puts Prenetics Global Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 25, 2026